{"id":1138581,"title":"DSEN Abstract: Hydromorphone controlled release drug injection and hepatitis C virus (HCV), and human immunodeficiency virus (HIV) and infectious endocarditis (IE) infection - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-20","captureTimestamp":"2026-02-20T22:25:23.174000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53997.html","snippet":"DSEN Abstract Hydromorphone controlled release drug injection and hepatitis C virus (HCV), and human immunodeficiency virus (HIV) and infectious endocarditis (IE) infection Injecting oral hydromorphone can lead to serious infections. We observed a higher incidence of HCV…","rawSnapshotUrl":"/api/snapshots/raw/1138581","browseUrl":"https://replay.healtharchive.ca/job-8/20260220222523/https://cihr-irsc.gc.ca/e/53997.html#ha_snapshot=1138581","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}